Patent · US Active

Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections

US9663474B2 · kind B2 · utility

27Cited by

0References

9Claims

0Family size

Assignee

Janssen Sciences Ireland UC · IE

Inventors

Stefaan Julien Last · Lint, BE
David Craig McGowan · Vilvoorde, BE
Werner Constant Johan Embrechts · Beerse, BE
Serge Maria Aloysius Pieters · Wichelen, BE
Tim Hugo Maria Jonckers · Heist-op-den-Berg, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE

Key dates

Filing date	Nov 15, 2013
Grant date	May 30, 2017
Priority date	—
Expiry date	Nov 15, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This invention relates to heterocyclic substituted 2-amino-quinazoline derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.